is there a role for combination therapy in cml?
Published 20 hours ago • 19 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
26:14
how to treat chronic myeloid leukemia (cml) - dr. jorge cortes
-
5:35
interview jorge cortes
-
4:15
jorge cortes, md, on the evolution of cml treatment, remaining challenges
-
8:25
interview timothy hughes and jorge cortes
-
2:06
dr. jorge cortes discusses the ponatinib ph all and cml evaluation (pace) trial
-
1:27
jorge cortes, md, discusses the take home message from the optic study in cml patients for hcps
-
1:01
dr. cortes discusses ponatinib as initial therapy for cml
-
0:57
dr. cortes discusses tki cessation in cml
-
2:32
bosutinib in newly diagnosed cml: gi, liver, effusion, and renal safety characterization
-
1:43
dr. jorge cortes on the phase ii ponatinib pace trial
-
22:31
knowledge centre: cml therapy - frontline therapy
-
5:10
jorge e cortes asco20: interim analysis of the phase ii optic trial of ponatinib in cp-cml
-
0:46
dr. cortes on tyrosine kinase inhibitors in cml
-
8:00
dr. cortes discusses approval of ponatinib for adults with chronic-phase cml
-
1:19
novel combination therapy for cmml: jak inhibitor pacritinib plus azacitidine
-
4:25
updated results from cartitude-1: phase 1b/2study of cilta-cel in pts with rr multiple myeloma
-
3:13
selection for time-limited & continuous therapy in cll
-
1:14
select-monotherapy trial: dr. mike putman
-
8:00
when to switch therapy in chronic myeloid leukemia